pharmaphorum

JANUARY 18, 2022

Main Conference: April 25 – 26, 2022 | Workshops: April 27, 2022. Chair for 2022: Gretchen Vandal, Sr. Featured 2022 Speakers Include: Joyce Zhao, Associate Director, Combination Product, Takeda. Primary Packaging material designers. Secondary packagers. SMi’s 9th Annual Conference. Drug developers.

Packaging 52

Packaging Documentation Vaccines Drug Development 52

pharmaphorum

FEBRUARY 28, 2022

As part of SMi’s leading series of drug delivery device conferences, the 2022 event will provide insights into the rapidly accelerating market of combination product development with industry, device developer and regulatory perspectives. Chairs for 2022: Tina Rees, Associate Director, Human Factors, Regeneron Pharmaceuticals.

Packaging 52

Packaging Vaccines Drug Development 52

European Pharmaceutical Review

MAY 29, 2023

Nanoparticle HIV vaccine shows potential in trial Nanomedicines generally require aseptic processing. described that while robotics is currently already widely used at the secondary packaging stage, the coming years will see large adoption of robots in aseptic manufacturing environments too. Tanzini et al.

Process Improvement 95

Process Improvement Packaging Vaccines Drug Development 95

European Pharmaceutical Review

SEPTEMBER 22, 2023

According to a report by Research Nester, the global aseptic packaging market is projected to reach a revenue of $35 billion by 2033 and is estimated to reach a compound annual growth rate (CAGR) of 10 percent between 2023 and 2033. The post Aseptic packaging market to value $35bn by 2033 appeared first on European Pharmaceutical Review.

Packaging 105

Packaging Vaccines Compounding 105

RX Note

APRIL 12, 2025

New individual users receives a 14-day free trial to the UpToDate Lexidrug Hospital Pharmacist Package. LactRx LactRx by MotherToBaby is a free app designed to provide current information regarding the use of medications, vaccines, diagnostic agents and drugs of misuse while breastfeeding.

Health and Personal Care Stores 52

Health and Personal Care Stores Compounding Packaging Hospitals 52

pharmaphorum

FEBRUARY 3, 2022

There is a rising demand for vaccines, insulin, and many modern medicines used to treat cancer and other chronic diseases. The post Injectable Drug Delivery 2022 appeared first on. Who should attend: Executives, Directors, VPs, Heads, Principals, Managers, Scientists, Researchers of: Autoinjectors. Device Engineering. Human Factors.

Compounding 52

Compounding Packaging Biosimilars Vaccines 52

Pharmaceutical Technology

MARCH 22, 2023

Only 25% of API production for generic drugs took place in Europe in 2020, according to a November 2022 Medicines for Europe report. Due to the cessation of Russian gas imports following its invasion of Ukraine, electricity prices increased up to tenfold, and raw material costs rose by 50% to 160% in Q3 2022.

Pharmaceutical Manufacturing 105

Pharmaceutical Manufacturing Packaging Communication Diabetes 105

Express Pharma

DECEMBER 11, 2023

The COVID-19 pandemic also highlighted the vital role of the cold chain in ensuring patient safety during vaccine distribution. And, with India’s vaccine, biopharma, and clinical trials market projected to grow in double-digits, there will be an increasing demand for efficient cold chain facilities. billion in 2022.

Packaging 115

Packaging Vaccines 115

Pharmaceutical Technology

FEBRUARY 3, 2023

With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more. CEVEC became part of Cytiva in October 2022. 1] BioNews.

Communication 97

Communication Dosage Packaging Vaccines 97

pharmaphorum

JANUARY 27, 2023

It’s wise advice from the “Sage of Omaha”; indeed, one highly respected financial newspaper began its 2023 predictions by conceding that it had been wrong on five major counts for 2022. The same goes for many commodities used in the production process for key medicines, from solvents through to packaging.

Packaging 105

Packaging Biosimilars Vaccines 105

Express Pharma

AUGUST 20, 2023

Both Johnson & Johnson and Pfizer criticised the changes by referencing the positive role of patents in incentivising their vaccine production during the COVID-19 pandemic. In 2022, there were $37 billion in global sales of Pfizer’s Comirnaty and over $2 billion of J&J’s Jcovden.

Packaging 98

Packaging Vaccines Drug Development 98

Pharmaceutical Technology

AUGUST 16, 2022

Even giant pharma companies with large internal production capabilities are leaning on outsourcing to meet market demand for huge numbers of injectables, including high-value biologics and Covid-19 vaccines, according to a GlobalData analysis. Outsourcing may also be pursued if it is more favourable in terms of time and/or cost.

Packaging 64

Packaging Vaccines 64

Pharmaceutical Technology

MARCH 22, 2023

According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. In addition, in 2022, non-new molecular entity (NME) injectables approvals were the highest they have been for the last decade.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

DECEMBER 26, 2023

Advanced inducible systems to better regulate the expression of certain genes will improve the generation of packaging and producer cell clones, giving companies more control over gene expression for improved safety as well as efficiency. Scientific American; 2022 [cited 2023 Jun]. 2022 [cited 2023 Jun]. Trends in Biotechnology.

Drug Pricing 98

Drug Pricing Packaging Vaccines Drug Development 98

pharmaphorum

NOVEMBER 27, 2022

Incidents such as the hormone replacement therapy drug shortage in early 2022 have shown the damaging impact supply chain issues can have on people who depend on these drugs. It’s imperative that all suppliers and distributors know if disruption is likely to occur, whether that be concerning incoming raw materials or outgoing packaged drugs.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105

Fuld & Company Blog

MAY 15, 2023

In addition, in-person care would be available for follow-up care, vaccinations, or blood draws through a registered nurse who would be made available at a location of the patients’ choosing, at home or in the office. Soon after its soft launch, Amazon began testing the idea with potential corporate clients, but had little success.

Health and Personal Care Stores 59

Health and Personal Care Stores Mail-Order Pharmacies Packaging Medication Delivery 59

European Pharmaceutical Review

NOVEMBER 14, 2023

In response to supply chain challenges, including shortages of critical glass vials for products like COVID-19 vaccines and parenteral drugs, the Packaging and Distribution Expert Committee (PD EC) has made a significant revision of United States Pharmacopeia (USP) General Chapter <660>—Glass.

Packaging 105

Packaging Vaccines Documentation 105

Express Pharma

JANUARY 12, 2024

Initiatives such as Ayushmaan Bharat Digital Mission (“ADBDM”), CoWIN (a digital vaccine delivery platform), health registry, and telemedicine, highlight the government’s strong emphasis on digitisation of health in India. The time for commencing manufacturing or production was extended to 31 March 2024 by the Finance Act, 2022.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Pharmaceutical Companies Pharmaceutical Companies Health Insurance Companies 52

epicur

JULY 12, 2023

The unit-dose blister packaging offers key advantages and safer handling for veterinary staff and pet owners. Cancer vaccines—Cancer vaccines train the immune system to identify specific proteins produced by a tumor. Learn more about the benefits. Monitoring for relapse. Oncept®, used to treat canine melanoma, is an example.

Chemotherapy 85

Chemotherapy Immunity Immunization Vaccines 85

Pharma in Brief

JANUARY 9, 2022

In response to the COVID-19 pandemic, in 2020, the Minister of Health signed interim orders designed to streamline the process to authorize the importation or sale of drugs, vaccines, and medical devices used to diagnose, treat, mitigate, or prevent COVID-19. The Amendments and the accompanying Guidelines are still not in force.

Documentation 52

Documentation Labelling Vaccines Packaging 52

European Pharmaceutical Review

MARCH 1, 2023

Nowhere is this more publicly evident than in the development, regulatory approval, and efficacious use of mRNA‑based vaccines for COVID-19. Beyond the high-profile COVID-19 vaccines, mRNA therapeutics are crucial in applications such as protein replacement therapies and regenerative medicine. 2014 Nov 20; 56(4), 506‑17.

Vaccines 111

Vaccines Packaging 111

PharmaShots

MARCH 9, 2023

Designation: Chief Commercial Officer (CCO) and President Award & Nominations: She has her mention in Fortune’s “Top 50 Most Powerful Women” in 2020, 2021, and 2022 ranking 16th, 11th, and 13th respectively. Hatfield Economic Fellow at Cornell University in 2022. She was also selected as the 39th Robert S.

Clinical Pharmacology 40

Clinical Pharmacology Immunity Immunization Pharmaceutical Companies 40

Pharmaceutical Technology

JUNE 9, 2023

After a long period without any new approvals, in May, the FDA approved GSK’s vaccine Arexvy for the prevention of LRTD caused by RSV in individuals 60 and older. On 31 May, the FDA also approved Pfizer’s vaccine Abrysvo in the same patient population. The European Commission approved nirsevimab in November 2022.

Vaccines 59

Vaccines Packaging 59

Pharmaceutical Technology

DECEMBER 12, 2022

In this last 2022 edition of the series, which started in June , Pharmaceutical Technology is tracking major trial announcements and decisions by regulators and reimbursement agencies that have occurred since mid-October, as well as their potential impact on manufacturing plans. Iomab-B met the durable complete remission endpoint.

Packaging 59

Packaging Vaccines Pharmaceutical Companies Pharmaceutical Companies 59

Pharmaceutical Technology

NOVEMBER 9, 2022

At the start of 2022 alone, BenevolentAI partnered with AstraZeneca and Exscientia joined forces with Sanofi in deals designed to combine the efficiency-maximising power of AI-driven start-ups with the scale and reach of vaccine producing conglomerates. Digital transformation is permeating the entire pharmaceutical supply chain. “As

Vaccines 52

Vaccines Packaging Communication 52

Pharmaceutical Technology

DECEMBER 9, 2022

Rankings 2022. The company is ranked in the M&A, PRODUCT LAUNCHES and RESEARCH AND DEVELOPMENT categories in the 2022 Pharmaceutical Technology Excellence Rankings. The company is ranked in the M&A, PRODUCT LAUNCHES and RESEARCH AND DEVELOPMENT categories in the 2022 Pharmaceutical Technology Excellence Rankings.

Vaccines 52

Vaccines Biosimilars Compounding Packaging 52

European Pharmaceutical Review

AUGUST 18, 2022

Merck (MSD outside of the US and Canada) has entered into a collaboration agreement with Orna Therapeutics to discover, develop and commercialise multiple programmes of engineered circular RNA (oRNA) therapies, including vaccines and therapeutics in the areas of infectious disease and oncology.

Vaccines 98

Vaccines Research Laboratories Packaging 98

pharmaphorum

DECEMBER 13, 2021

It started with two Covid-19 vaccines – 2021 is the year interest in mRNA therapeutics boomed, reports Katrina Megget. The Covid-19 pandemic showed what could be done with resources and collaboration to accelerate the development of vaccines. There are multiple other mRNA vaccines that are being developed.

Vaccines 105

Vaccines Packaging 105

Pharmaceutical Technology

JULY 29, 2022

Pfizer (New York, New York) and Moderna’s (Cambridge, Massachusetts) Omicron-specific Covid-19 vaccines are in late-stage development, have demonstrated good efficacy against the variant and will likely be available to the public later this year to provide an additional booster and increase demand for injectable manufacturing.

Vaccines 52

Vaccines Packaging Immunity Immunization 52

Pharmaceutical Technology

JULY 4, 2022

US President Joe Biden has gained approval from Congress for a new package of aid worth $40bn, and the US government announced last month that it plans to provide an additional $1bn in security assistance to Ukraine. million vaccine doses upon EMA authorisation.

Vaccines 122

Vaccines Packaging 122

Pharmacy Friday Pearls

MARCH 4, 2022

1 risk factor for progression to severe disease a No prior COVID-19 vaccine or infectionStandard of care treatment allowed but primary analysis population was limited to subjects who did NOT receive COVID-19 monoclonal antibodies COVID-19 related hospitalizations/death through day 28: 0.8% 18 years Study included patients ? Paxlovid vs. 6.3%

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Hospitals Packaging Immunity 40

PharmaShots

JUNE 1, 2023

PDC*line is much more potent than conventional dendritic cell-based vaccines in priming and boosting antitumor antigen-specific cytotoxic T-cells, including the T-cells specific for neoantigens, and is synergistic with checkpoint inhibitors. These new results reinforce our differentiating data package for PDC*lung01.

Immunization 40

Immunization Immunity Vaccines Health and Personal Care Stores 40

RX Note

APRIL 21, 2023

Management Based on Disease Severity Regardless of vaccination status, COVID-19 positive cases must quarantine for 7 days from the day they received the positive test result. for all of KL from May 7, 5 May 2021 180k Sinovac vaccine doses bottled by Pharmaniaga to be ready this week, 10 May 2021 Nationwide MCO 3.0 Test if symptoms.

Vaccines 40

Vaccines Health and Personal Care Stores Hospitals Packaging 40

RX Note

FEBRUARY 23, 2023

Figures - Elemental iron and calcium content?

HIV Treatment and Prevention Agents 58

HIV Treatment and Prevention Agents Community Pharmacies Labelling Chemotherapy 58

pharmaphorum

JANUARY 22, 2021

What this means for the pharma industry is likely business as usual, at least until the midterm elections in 2022.” He’ll probably want greater investment in biodefense so the country can increase its stockpile ahead of the next pandemic event, which may increase industry focus on vaccines, antivirals and antibiotics.”

Drug Pricing 63

Drug Pricing Packaging Biosimilars Pharmaceutical Companies 63